Abstract
Measurements of erythrocytes within the blood are important clinical traits and can indicate various hematological disorders. We report here genome-wide association studies (GWAS) for six erythrocyte traits, including hemoglobin concentration (Hb), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and red blood cell count (RBC). We performed an initial GWAS in cohorts of the CHARGE Consortium totaling 24,167 individuals of European ancestry and replication in additional independent cohorts of the HaemGen Consortium totaling 9,456 individuals. We identified 23 loci significantly associated with these traits in a meta-analysis of the discovery and replication cohorts (combined P values ranging from 5 × 10−8 to 7 × 10−86). Our findings include loci previously associated with these traits (HBS1L-MYB, HFE, TMPRSS6, TFR2, SPTA1) as well as new associations (EPO, TFRC, SH2B3 and 15 other loci). This study has identified new determinants of erythrocyte traits, offering insight into common variants underlying variation in erythrocyte measures.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Havlik, R.J. et al. Evidence for additional blood pressure correlates in adults 20–56 years old. Circulation 61, 710–715 (1980).
Tell, G.S. et al. Correlates of blood pressure in community-dwelling older adults. The Cardiovascular Health Study. Cardiovascular Health Study (CHS) Collaborative Research Group. Hypertension 23, 59–67 (1994).
Zakai, N.A. et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch. Intern. Med. 165, 2214–2220 (2005).
Whitfield, J.B. & Martin, N.G. Genetic and environmental influences on the size and number of cells in the blood. Genet. Epidemiol. 2, 133–144 (1985).
Evans, D.M., Frazer, I.H. & Martin, N.G. Genetic and environmental causes of variation in basal levels of blood cells. Twin Res. 2, 250–257 (1999).
Lin, J.P. et al. Evidence for linkage of red blood cell size and count: genome-wide scans in the Framingham Heart Study. Am. J. Hematol. 82, 605–610 (2007).
McLaren, C.E. et al. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study. Am. J. Hematol. 82, 898–905 (2007).
Zeng, S.M., Yankowitz, J., Widness, J.A. & Strauss, R.G. Etiology of differences in hematocrit between males and females: sequence-based polymorphisms in erythropoietin and its receptor. J. Gend. Specif. Med. 4, 35–40 (2001).
Zeng, S.M., Yankowitz, J., Widness, J.A. & Strauss, R.G. Sequence-based polymorphisms in members of the apoptosis Bcl-2 gene family and their association with hematocrit level. J. Gend. Specif. Med. 6, 36–42 (2003).
Menzel, S. et al. The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans. Blood 110, 3624–3626 (2007).
Iliadou, A. et al. Genomewide scans of red cell indices suggest linkage on chromosome 6q23. J. Med. Genet. 44, 24–30 (2007).
Yang, Q., Kathiresan, S., Lin, J.P., Tofler, G.H. & O'Donnell, C.J. Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC Med. Genet. 8 (Suppl. 1), S12 (2007).
Lin, J.P., O'Donnell, C.J., Levy, D. & Cupples, L.A. Evidence for a gene influencing haematocrit on chromosome 6q23–24: genomewide scan in the Framingham Heart Study. J. Med. Genet. 42, 75–79 (2005).
Psaty, B.M. et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from five cohorts. Circ. Cardiovasc. Genet. 2, 73–80 (2009).
Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677–687 (2009).
Agre, P., Casella, J.F., Zinkham, W.H., McMillan, C. & Bennett, V. Partial deficiency of erythrocyte spectrin in hereditary spherocytosis. Nature 314, 380–383 (1985).
Marchesi, S.L. et al. Mutant forms of spectrin alpha-subunits in hereditary elliptocytosis. J. Clin. Invest. 80, 191–198 (1987).
Feder, J.N. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13, 399–408 (1996).
Roest, M. et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 100, 1268–1273 (1999).
Tuomainen, T.P. et al. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100, 1274–1279 (1999).
Vecchi, C. et al. ER stress controls iron metabolism through induction of hepcidin. Science 325, 877–880 (2009).
Swinkels, D.W. & Wetzels, J.F. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol. Dial. Transplant. 23, 2450–2453 (2008).
Roy, C.N. et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109, 4038–4044 (2007).
Feder, J.N. et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. USA 95, 1472–1477 (1998).
Finberg, K.E. et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat. Genet. 40, 569–571 (2008).
Kerenyi, M.A. et al. Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. Blood 112, 3878–3888 (2008).
Roetto, A. et al. Hemochromatosis due to mutations in transferrin receptor 2. Blood Cells Mol. Dis. 29, 465–470 (2002).
Uda, M. et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl. Acad. Sci. USA 105, 1620–1625 (2008).
Menzel, S. et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 39, 1197–1199 (2007).
Bea, S. et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 106, 3183–3190 (2005).
Sankaran, V.G. et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322, 1839–1842 (2008).
Higgs, D.R. & Wood, W.G. Genetic complexity in sickle cell disease. Proc. Natl. Acad. Sci. USA 105, 11595–11596 (2008).
Sandberg, M.L. et al. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev. Cell 8, 153–166 (2005).
Emambokus, N. et al. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J. 22, 4478–4488 (2003).
Gudbjartsson, D.F. et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41, 342–347 (2009).
Newton-Cheh, C. et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 41, 666–676 (2009).
Todd, J.A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857–864 (2007).
Hunt, K.A. et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat. Genet. 40, 395–402 (2008).
Smyth, D.J. et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 359, 2767–2777 (2008).
Velazquez, L. et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J. Exp. Med. 195, 1599–1611 (2002).
Saxton, T.M. et al. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16, 2352–2364 (1997).
Jongmans, M. et al. Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature. Am. J. Med. Genet. A. 134A, 165–170 (2005).
Kalidas, K. et al. Genetic heterogeneity in LEOPARD syndrome: two families with no mutations in PTPN11. J. Hum. Genet. 50, 21–25 (2005).
Tartaglia, M. et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34, 148–150 (2003).
Tong, Z. et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc. Natl. Acad. Sci. USA 105, 6998–7003 (2008).
Wannamethee, G. & Shaper, A.G. Haematocrit: relationships with blood lipids, blood pressure and other cardiovascular risk factors. Thromb. Haemost. 72, 58–64 (1994).
Gagnon, D.R., Zhang, T.J., Brand, F.N. & Kannel, W.B. Hematocrit and the risk of cardiovascular disease—the Framingham study: a 34-year follow-up. Am. Heart J. 127, 674–682 (1994).
Elwood, P.C., Waters, W.E., Benjamin, I.T. & Sweetnam, P.M. Mortality and anaemia in women. Lancet 1, 891–894 (1974).
Sarnak, M.J. et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J. Am. Coll. Cardiol. 40, 27–33 (2002).
de Simone, G. et al. Association of blood pressure with blood viscosity in american indians: the Strong Heart Study. Hypertension 45, 625–630 (2005).
Letcher, R.L., Chien, S., Pickering, T.G. & Laragh, J.H. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 5, 757–762 (1983).
Sharp, D.S. et al. Mean red cell volume as a correlate of blood pressure. Circulation 93, 1677–1684 (1996).
Wells, R.E. Jr. & Merrill, E.W. Influence of flow properties of blood upon viscosity-hematocrit relationships. J. Clin. Invest. 41, 1591–1598 (1962).
Ott, E.O., Lechner, H. & Aranibar, A. High blood viscosity syndrome in cerebral infarction. Stroke 5, 330–333 (1974).
Gollob, M.H. et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N. Engl. J. Med. 344, 1823–1831 (2001).
Gollob, M.H. et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 104, 3030–3033 (2001).
Beutler, E. & Waalen, J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 107, 1747–1750 (2006).
Servin, B. & Stephens, M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 3, e114 (2007).
Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
Watkins, N.A. et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood 113, e1–e9 (2009).
da Costa Martins, P. et al. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler. Thromb. Vasc. Biol. 27, 1023–1029 (2007).
Du, P., Kibbe, W.A. & Lin, S.M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547–1548 (2008).
Hamosh, A (ed.). Online Mendelian Inheritance in Man (McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, Maryland, USA) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, Maryland, USA)). <http://www.ncbi.nlm.nih.gov/omim>.
Becker, K.G., Barnes, K.C., Bright, T.J. & Wang, S.A. The genetic association database. Nat. Genet. 36, 431–432 (2004).
Acknowledgements
Complete study acknowledgments are listed in the Supplementary Note. The authors thank the studies' participants and staff and the funding agencies for their support.
Author information
Authors and Affiliations
Contributions
AGES: Study design and phenotype collection, T.B.H.,V.G., L.J.L., G.E.; data analysis, A.V.S., M.A.N., T.A.; manuscript preparation, M.A.N., N.S.; manuscript revisions, T.B.H.,V.G., L.J.L., A.V.S., A.B.S., D.G.H., M.A.N. ARIC: Study design and phenotype collection, E.B., J.C., S.F., A.C.; genotyping, E.B., A.C.; data analysis, S.K.G., A.K., A.C., A.G., G.B.E., A.J.; manuscript preparation, S.K.G., S.F.; manuscript revisions, S.K.G., A.C., E.B., J.C., A.K., S.F. CHS: Study design and phenotype collection, B.M.P., J.I.R., M.C., N.A.Z., N.L.G.; genotyping, J.I.R.; data analysis, N.L.G, T.L.; manuscript preparation, N.A.Z.; manuscript revisions, B.M.P., J.C.M.B., K.R., J.I.R., M.C., N.A.Z., N.L.G., T.L. FHS: Study design and phenotype collection, M.-H.C., Q.Y., C.S.F., D.L., L.A.C., C.J.O., J.-P.L.; data analysis, M.-H.C., Q.Y., J.-P.L., G.Z.; manuscript preparation, M.-H.C., C.J.O., J.-P.L.; manuscript revisions, M.-H.C., Q.Y., C.S.F., D.L., L.A.C., C.J.O., J.-P.L. Rotterdam: Study design and phenotype collection, F.J.A.v.R., A.H., A.G.U., B.A.O., C.M.v.D., J.C.M.W.; genotyping, A.G.U.; data analysis, F.J.A.v.R., J.F.F., A.D., G.C.V.; manuscript preparation, F.J.A.v.R., J.F.F., C.M.v.D.; manuscript revisions, F.J.A.v.R., J.F.F., A.D., G.C.V., A.H., A.G.U., B.A.O., C.M.v.D., J.C.M.W. InCHIANTI: Study design and phenotype collection, L.F., J.M.G., S.B.; data analysis, M.A.N., T.T.; manuscript preparation, M.A.N.; manuscript revisions, L.F., J.M.G., S.B., K.V.P., A.B.S., D.G.H., M.A.N., T.T. HaemGen: A.R., J.-J.Z., J.M.vG. Twins UK: Study design and phenotype collection, T.D.S., S.-L.T., P.D.; data analysis and manuscript preparation and revisions, N.S. UKBS1: Study design and phenotype collection, W.H.O., J.G.S.; data analysis, N.S.; manuscript preparation and revisions, N.S., A.R. KORA: Study design and phenotype collection, C.M., C.G.; data analysis, C.G., B.K.; manuscript preparation and revisions, C.G. SHIP: Study design and phenotype collection, M.N., A.G.; data analysis, A.T.; gene expression, A.R., J.-J.Z., J.M.vG.
Corresponding authors
Ethics declarations
Competing interests
A. Chakravarti is a paid member of the Scientific Advisory Boards of Affymetrix and Pyxis Genomics. These potential conflicts of interest are managed by the policies of Johns Hopkins University School of Medicine.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1, 2, 4 and 5, Supplementary Figures 1 and 2, and Supplementary Note (PDF 3493 kb)
Supplementary Table 3
All CHARGE meta analysis results. (XLS 288 kb)
Rights and permissions
About this article
Cite this article
Ganesh, S., Zakai, N., van Rooij, F. et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 41, 1191–1198 (2009). https://doi.org/10.1038/ng.466
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.466
This article is cited by
-
Exploring quantitative traits-associated copy number deletions through reanalysis of UK10K consortium whole genome sequencing cohorts
BMC Genomics (2023)
-
Identification of a genomic DNA sequence that quantitatively modulates KLF1 transcription factor expression in differentiating human hematopoietic cells
Scientific Reports (2023)
-
The genetics of human performance
Nature Reviews Genetics (2022)
-
Fount, fate, features, and function of renal erythropoietin-producing cells
Pflügers Archiv - European Journal of Physiology (2022)
-
Investigating the genetic architecture of disease resilience in pigs by genome-wide association studies of complete blood count traits collected from a natural disease challenge model
BMC Genomics (2021)